Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.
Financial Results:
Ajanta Pharma Ltd reported Revenues for Q1FY25 of ₹1,145.00 Crores up from ₹1,021.00 Crore year on year, a rise of 12.14%.
Total Expenses for Q1FY25 of ₹850.00 Crores up from ₹784.00 Crores year on year, a rise of 8.42%.
Consolidated Net Profit of ₹246.00 Crores up 18.27% from ₹208.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹19.52, up 18.09% from ₹16.53 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.